Search for: "Novartis Pharma AG " Results 1 - 20 of 124
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Feb 2015, 9:43 pm by Patent Docs
Novartis AG et al. v. [read post]
1 Dec 2013, 8:49 pm by Patent Docs
Roxane Laboratories, Inc. 2:13-cv-07184; filed November 27, 2013 in the District Court of New Jersey • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis Pharma AG; Aventisub II Inc. [read post]
7 Apr 2013, 9:37 pm by Patent Docs
Noven Pharmaceuticals Inc. et al. 1:13-cv-00527; filed April 3, 2013 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; Novartis International Pharmaceutical Ltd.; LTS Lohmann Therapie-Systeme AG • Defendants: Noven Pharmaceuticals Inc.; Noven Therapeutics LLC; Hisamitsu Pharmaceutical Co. [read post]
3 Feb 2014, 9:51 pm by Patent Docs
Noven Pharmaceuticals Inc. et al. 1:14-cv-00111; filed January 30, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; Novartis International Pharmaceutical, LTD; LTS Lohmann Therapie-Systeme AG • Defendants: Noven Pharmaceuticals Inc.; Noven Therapeutics LLC; Hisamitsu Pharmaceutical Co. [read post]
29 Jun 2014, 9:21 pm by Patent Docs
Mylan Inc. et al. 1:14-cv-00777; filed June 19, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; LTS Lohmann Therapie-Systeme AG • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc. [read post]
7 Jan 2021, 1:32 pm by Tom Lamb
To start, Beovu was approved by the FDA on October 7, 2019, to treat wet age-related macular degeneration. [read post]
22 Jul 2012, 9:13 pm by Patent Docs
Sun Pharmaceuticals Industries, Inc. et al. 2:12-cv-04393; filed July 14, 2012 in the District Court of New Jersey • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis Corp.; Novartis AG • Defendants: Sun Pharmaceuticals Industries, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd; Sun Pharmaceutical Industries Ltd. [read post]
The court said that the generic companies’ manufacturing or selling of these tablets may amount to infringement of a patent owned by major pharmaceutical company Novartis AG. [read post]
29 Jun 2018, 11:13 am
In its ruling,  the Court ordered Teva to pay Novartis more than €13,000,000 as an advance on damages (€5,846,628 to Novartis Pharma AG, the Swiss company which owns the patent, and €7,308,285 to Novartis Pharma SAS, the French licensee). [read post]
8 Nov 2009, 9:28 pm
Novartis AG et al. v. [read post]
12 Apr 2017, 9:52 am by Lawrence B. Ebert
Patent No.8,324,283 (the ’283 patent), owned by Novartis AG andMistubishi Tanabe Pharma Corp. [read post]
4 Mar 2020, 1:56 pm by Tom Lamb
Most of the cases have started after patients’ first or second injection of the wet age-related macular degeneration (AMD) drug, Novartis said. [read post]
13 Feb 2011, 9:08 pm by Patent Docs
Mylan Pharmaceuticals Inc. et al. 1:11-cv-00127; filed February 10, 2011 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
22 Feb 2015, 9:59 pm by Patent Docs
Pfizer, Inc. 2:15-cv-01283; filed February 18, 2015 in the District Court of New Jersey • Plaintiffs: Novartis Vaccines and Diagnostics, Inc.; Novartis Pharma AG • Defendant: Pfizer, Inc. [read post]
21 Apr 2017, 6:15 am by Joseph Robinson
The Federal Circuit affirmed a Patent Trial and Appeal Board (“Board”) decision finding a patent owned by Novartis AG and Mitsubishi Tanabe Pharma Corp. [read post]
2 Apr 2013, 12:44 pm by Jack McNeill
In a case that may have world-wide ramifications the Supreme Court of India has ruled in Novartis AG v. [read post]
4 Mar 2009, 2:47 am
High Court (Administrative Court) Haw, R (on the application of) v Southwark Crown Court & Ors [2009] EWHC 379 (Admin) (03 March 2009) High Court (Patents Court) Novartis AG v Dexcel-Pharma Ltd [2009] EWHC 336 (Pat) (03 March 2009) Source: www.bailii.org [read post]
23 Jan 2009, 9:59 pm
By Jason Derry --Peptimmune and Novartis Sign $500 Million Deal Peptimmune Inc. and Novartis AG recently announced a licensing deal for Peptimmune's multiple sclerosis drug candidate, PI-2301. [read post]
13 Apr 2014, 9:43 pm by Patent Docs
Reddy's Laboratories Ltd. et al. 1:14-cv-00387; filed March 26, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendants: Dr. [read post]